Gv
GV is an independent venture-capital firm that states it invests from seed to growth stages. Its principal sectors are AI, consumer, enterprise, life sciences, and frontier technology, with support that includes operating partners and connections to Google and Alphabet companies.
GV presents a multi-stage venture-capital platform with a broad technology and life-sciences mandate.
It states that it invests from seed to growth, operates on long time horizons, and supports founding teams through operating partners and connections to Google and Alphabet companies.[1][2]
What does Gv invest in?
GV states that it launched as Google Ventures in 2009 and later became GV, operating as an independent venture-capital firm for innovative founders. The firm states that it invests from seed to growth stages and supports founding teams through operating partners and connections to Google and Alphabet companies.
GV’s official About page reports over $13 billion in assets under management, 400 active portfolio companies, 80 IPOs, and more than 230 M&A outcomes.[1]
GV states that it invests from seed through growth stages and operates on long time horizons, describing its approach as dealing in decades rather than rounds. Its stated support model includes operating partners covering executive talent, communications, and marketing, together with connections to Google and Alphabet companies.
GV also states that Alphabet is its sole limited partner and that the firm has autonomy to invest in direct competitors.[1]
Owners comparing capital alternatives can review Auxo’s capital advisory services, valuation services, and full-versus-partial sale framework.
What should a business owner evaluate before taking capital from Gv?
For an owner evaluating GV as a capital partner, the public record establishes a seed-to-growth mandate, a broad technology and life-sciences focus, operating-partner support, connections to Google and Alphabet companies, and a stated long-horizon approach. The firm’s stated autonomy to invest in direct competitors also makes conflict and information-sharing arrangements a point for transaction-specific diligence.
The cited GV portfolio page does not disclose company-by-company ownership percentages or consideration terms, and the cited About page does not disclose detailed capital-allocation schedules. Security terms, governance rights, follow-on allocations, and the boundaries of operating and Alphabet-related support should be confirmed for the proposed investment, along with the relevant GV legal entity and fund.[1][2]
Which GV legal entity and fund would make the investment
What ownership percentage, security type, liquidation preference, governance rights, and information rights are expected
How much follow-on capital is reserved for the company and under what conditions
What investment criteria does Gv publicly describe?
GV invests in companies rather than serving as a broker or transaction advisor. Its official portfolio materials identify companies across AI, consumer, enterprise, life sciences, and frontier technology. The portfolio page marks exited companies with an asterisk.[2]
GV states that it invests from seed to growth stages and seeks innovative founders across technology and life sciences. The public materials identify the firm’s principal sectors. The cited GV portfolio page does not disclose company-by-company ownership percentages or consideration terms, and the cited About page does not disclose detailed capital-allocation schedules.[1][2]
GV states that it supports active portfolio companies across North America, Europe, and Israel. Its listed offices are in the San Francisco Bay Area, New York, Cambridge, and London.[1]
Recent official GV announcements identify investments in Nebex, MokN, Recursive Superintelligence, and Sierra. GV states that it led Nebex’s seed investment, led MokN’s Series A and joined the company’s board, co-led Recursive Superintelligence’s early $650 million funding at a $4.65 billion valuation, and co-led Sierra’s Series E financing.
The cited GV portfolio page does not disclose company-by-company ownership percentages or consideration terms.[2][5][6][7][8]
GV’s official news pages identify a June 29, 2026 announcement concerning its seed investment in Nebex, a May 28, 2026 announcement concerning MokN’s Series A, and a May 13, 2026 announcement concerning Recursive Superintelligence’s early funding. The official materials also identify GV as a co-lead in Sierra’s Series E financing.[5][6][7][8]
What is not clear from Gv's public materials?
The cited GV portfolio page lists company names and exit markers but does not disclose company-by-company investment dates, entry valuations, ownership percentages, or consideration terms.
The cited GV About page provides aggregate AUM and outcome counts but does not disclose fund-by-fund fee terms, fund-level return metrics, or detailed capital-allocation schedules.[1][2]
Questions to ask before taking capital from Gv
Which GV legal entity and fund would make the investment?
What ownership percentage, security type, liquidation preference, governance rights, and information rights are expected?
How much follow-on capital is reserved for the company and under what conditions?
Which operating partners or Alphabet resources would actually be available?
Can GV provide references from companies at a comparable stage and sector?
What is the expected investment horizon, and how does GV approach secondary sales, recapitalizations, or strategic exits?
What conflicts or information-sharing limits apply if GV has investments in direct competitors?
Sources & research notes
- Official website / firm overview
- Industry / market focus
- Industry focus
- Industry focus
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- SEC filing / regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.